EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische StudieVergleichsstudie

A Randomized, Controlled Trial Comparing PermeaDerm to Mepilex Ag for the Treatment of Adult and Pediatric Partial-Thickness Burns

David G Greenhalgh iD, David M Hill iD, Ram Velamuri, Ian Driscoll iD, Angela Gibson iD, Kevin Foster, David Smith, Aleisha Chamberlain, Katie Bush iD, Miao Yu iD

Journal of Burn Care & Research · 2025

DOI: 10.1093/jbcr/iraf013 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Burn Care & Research, 2025. Verfasst von David G Greenhalgh und 9 weiteren Autor:innen. Beteiligte Einrichtung: Burn Department, Shriners Children's Northern California, Sacramento, CA 95817, United States. Hauptthemen laut MEDLINE: Burns, Bandages. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 31 Literaturangaben. Gefördert von: Stedical Scientific, Inc.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A next-generation transparent biosynthetic wound matrix (PermeaDerm) was developed for the treatment of burn injuries. Improvements include slits in an outer 2D silicone epidermal analog allowing for customizable moisture control, and an updated biocoating of the nylon knitted fabric to optimize wound adherence. The purpose of this randomized, single-blinded, multicenter trial was to compare PermeaDerm to a commonly used silver-containing foam dressing (Mepilex Ag) for the treatment of partial-thickness burns. Patients with partial-thickness burns <30% TBSA treated within 72 hours were included. Primary outcomes included incidence of 100% re-epithelialization at 14 days and time to conversion to alternative therapy. Secondary outcomes included incidence of healing at 7 and 21 days, pain, number of product changes, and adverse events. Sixty-seven patients (42 pediatric, 25 adult) were analyzed, 32 with Mepilex Ag and 35 with PermeaDerm. Though not statistically significant, more patients achieved healing with PermeaDerm at day 14 (P = 0.36), particularly those with superficial partial-thickness injuries (OR 5.87, P = 0.203, 95% CI = 0.385, 89.580). This trend continued to day 21 (P = 0.25). At day 7, nonsignificant increased incidence of healing of Mepilex Ag-treated wounds was observed (P = 0.25), in addition, PermeaDerm was associated with lower needs for product changes (OR 0.15, P = 0.034, 95% CI = 0.027, 0.872); both observations likely attributable to the adherent nature of PermeaDerm. No significant differences in time to conversion to alternate therapies were noted. Overall pain scores, aesthetics, and adverse events, including infection, were similar between groups. PermeaDerm is a safe and effective treatment for partial-thickness burns. PermeaDerm offers the clinical advantages of being transparent to continuously monitor the wound and adherent, reducing the need for a product change and allowing for bathing after 72 hours.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BurnsBandagesHumansMaleFemaleAdultSingle-Blind MethodChildWound HealingMiddle AgedChild, PreschoolAdolescentTreatment OutcomeYoung AdultAgedRe-Epithelialization

Stichwörter der Autor:innen

burnsdressinghealingmatrixpartial-thicknesspediatrics

Autor:innen und Institutionen

  • Burn Department, Shriners Children's Northern California, Sacramento, CA 95817, United States.
  • Department of Surgery, University of California, Davis, Sacramento, CA 95817, United States.
  • Department of Pharmacy, Regional One Health, Memphis, TN 38103, United States.
  • Department of Surgery, Regional One Health, Memphis, TN 38103, United States.
  • Department of Surgery, University of Florida, Gainesville, FL, United States.
  • Department of Surgery, University of Wisconsin, Madison, WI, United States.

ORCID-Profile: David G Greenhalgh, David M Hill, Ian Driscoll, Angela Gibson, Katie Bush, Miao Yu

Förderung

  • Stedical Scientific, Inc

Zitieren

APA

Greenhalgh, D. G., Hill, D. M., Velamuri, R., Driscoll, I., Gibson, A., Foster, K., Smith, D., Chamberlain, A., Bush, K., & Yu, M. (2025). A Randomized, Controlled Trial Comparing PermeaDerm to Mepilex Ag for the Treatment of Adult and Pediatric Partial-Thickness Burns. Journal of Burn Care & Research. https://doi.org/10.1093/jbcr/iraf013

Vancouver

Greenhalgh DG, Hill DM, Velamuri R, Driscoll I, Gibson A, Foster K, et al. A Randomized, Controlled Trial Comparing PermeaDerm to Mepilex Ag for the Treatment of Adult and Pediatric Partial-Thickness Burns. Journal of Burn Care & Research. 2025. doi:10.1093/jbcr/iraf013

BibTeX
@article{Greenhalgh2025,
  author = {Greenhalgh, David G and Hill, David M and Velamuri, Ram and Driscoll, Ian and Gibson, Angela and Foster, Kevin and Smith, David and Chamberlain, Aleisha and Bush, Katie and Yu, Miao},
  title = {A Randomized, Controlled Trial Comparing PermeaDerm to Mepilex Ag for the Treatment of Adult and Pediatric Partial-Thickness Burns},
  journal = {Journal of Burn Care & Research},
  year = {2025},
  doi = {10.1093/jbcr/iraf013}
}
Kostenlos starten →